EL.En. S.p.A. engages in the production, research and development, distribution, and sale of laser systems in Italy, Rest of Europe, and internationally. The company offers laser systems for the medical sector and the industrial sector. It also develops, manufactures, and markets products, including solid-state laser, semiconductor laser, active fiber laser, dye lasers, and CO2 laser, as well as radio frequency, microwaves, frequency conversion systems, and high-intensity electromagnetic fields. In addition, the company is involved in medical research and development activities, such as body shaping, gynecology and urology, dermatology sector, and hair removal; industrial research and development, including metal cutting, dies, marking, and textile and jeans. EL.En. S.p.A. was founded in 1981 and is headquartered in Calenzano, Italy.…
EL.En. (BIT: ELN) is listed on Borsa Italiana, where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 1,345 employees.
The shares were at 16.34 EUR on 20 November 2026, up 44.7% over 52 weeks. Its 52-week range is 11.05 EUR to 17.64 EUR: the price is 7.4% below the high and 47.9% above the low.
At a market capitalisation of 1.31B EUR, it trades at 20.2 times trailing earnings and 18.5 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.5, a discount of 21% for ELN. It pays a dividend yielding 1.51% (it pays out 29% of its earnings), against a median of 2.35% among the dividend payers in that peer group.
EL.En. reports return on equity of 10.5%, an operating margin of 14.6% and revenue down 15.4% year over year.
It holds more cash than debt, a net cash position of 184.60M EUR. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 19.77 EUR is 21.0% above the current price. The next earnings report is expected on 15 March 2027.